Literature DB >> 16959034

CHARGE syndrome.

Kim D Blake1, Chitra Prasad.   

Abstract

CHARGE syndrome was initially defined as a non-random association of anomalies (Coloboma, Heart defect, Atresia choanae, Retarded growth and development, Genital hypoplasia, Ear anomalies/deafness). In 1998, an expert group defined the major (the classical 4C's: Choanal atresia, Coloboma, Characteristic ears and Cranial nerve anomalies) and minor criteria of CHARGE syndrome. Individuals with all four major characteristics or three major and three minor characteristics are highly likely to have CHARGE syndrome. However, there have been individuals genetically identified with CHARGE syndrome without the classical choanal atresia and coloboma. The reported incidence of CHARGE syndrome ranges from 0.1-1.2/10,000 and depends on professional recognition. Coloboma mainly affects the retina. Major and minor congenital heart defects (the commonest cyanotic heart defect is tetralogy of Fallot) occur in 75-80% of patients. Choanal atresia may be membranous or bony; bilateral or unilateral. Mental retardation is variable with intelligence quotients (IQ) ranging from normal to profound retardation. Under-development of the external genitalia is a common finding in males but it is less apparent in females. Ear abnormalities include a classical finding of unusually shaped ears and hearing loss (conductive and/or nerve deafness that ranges from mild to severe deafness). Multiple cranial nerve dysfunctions are common. A behavioral phenotype for CHARGE syndrome is emerging. Mutations in the CHD7 gene (member of the chromodomain helicase DNA protein family) are detected in over 75% of patients with CHARGE syndrome. Children with CHARGE syndrome require intensive medical management as well as numerous surgical interventions. They also need multidisciplinary follow up. Some of the hidden issues of CHARGE syndrome are often forgotten, one being the feeding adaptation of these children, which needs an early aggressive approach from a feeding team. As the child develops, challenging behaviors become more common and require adaptation of educational and therapeutic services, including behavioral and pharmacological interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959034      PMCID: PMC1586184          DOI: 10.1186/1750-1172-1-34

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  42 in total

1.  Temporal bone anomaly proposed as a major criteria for diagnosis of CHARGE syndrome.

Authors:  J Amiel; T Attieé-Bitach; R Marianowski; V Cormier-Daire; V Abadie; D Bonnet; M Gonzales; S Chemouny; F Brunelle; A Munnich; Y Manach; S Lyonnet
Journal:  Am J Med Genet       Date:  2001-03-01

Review 2.  Choanal atresia, CHARGE association, and congenital nasal stenosis.

Authors:  J L Keller; A Kacker
Journal:  Otolaryngol Clin North Am       Date:  2000-12       Impact factor: 3.346

3.  Mutations in a new member of the chromodomain gene family cause CHARGE syndrome.

Authors:  Lisenka E L M Vissers; Conny M A van Ravenswaaij; Ronald Admiraal; Jane A Hurst; Bert B A de Vries; Irene M Janssen; Walter A van der Vliet; Erik H L P G Huys; Pieter J de Jong; Ben C J Hamel; Eric F P M Schoenmakers; Han G Brunner; Joris A Veltman; Ad Geurts van Kessel
Journal:  Nat Genet       Date:  2004-08-08       Impact factor: 38.330

4.  The spectrum of clinical features in CHARGE syndrome.

Authors:  S L Davenport; M A Hefner; J A Mitchell
Journal:  Clin Genet       Date:  1986-04       Impact factor: 4.438

5.  Limb anomalies in the CHARGE association.

Authors:  P Meinecke; A Polke; P Schmiegelow
Journal:  J Med Genet       Date:  1989-03       Impact factor: 6.318

6.  Spectrum of congenital heart disease in CHARGE association.

Authors:  S E Cyran; R Martinez; S Daniels; P S Dignan; S Kaplan
Journal:  J Pediatr       Date:  1987-04       Impact factor: 4.406

7.  Exclusion of PITX2 mutations as a major cause of CHARGE association.

Authors:  Donna M Martin; Frank J Probst; Sharon E Fox; Lisa A Schimmenti; Elena V Semina; Margaret A Hefner; John W Belmont; Sally A Camper
Journal:  Am J Med Genet       Date:  2002-07-22

8.  Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association.

Authors:  R A Pagon; J M Graham; J Zonana; S L Yong
Journal:  J Pediatr       Date:  1981-08       Impact factor: 4.406

9.  Choanal atresia and associated multiple anomalies.

Authors:  B D Hall
Journal:  J Pediatr       Date:  1979-09       Impact factor: 4.406

10.  Colobomatous microphthalmia, heart disease, hearing loss, and mental retardation--a syndrome.

Authors:  H M Hittner; N J Hirsch; G M Kreh; A J Rudolph
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1979 Mar-Apr       Impact factor: 1.402

View more
  52 in total

1.  Kismet/CHD7 regulates axon morphology, memory and locomotion in a Drosophila model of CHARGE syndrome.

Authors:  David J Melicharek; Laura C Ramirez; Sukhdeep Singh; Rhea Thompson; Daniel R Marenda
Journal:  Hum Mol Genet       Date:  2010-08-17       Impact factor: 6.150

Review 2.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

3.  Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria.

Authors:  Caitlin L Hale; Adrienne N Niederriter; Glenn E Green; Donna M Martin
Journal:  Am J Med Genet A       Date:  2015-11-21       Impact factor: 2.802

4.  Clival Malformations in CHARGE Syndrome.

Authors:  E S Mahdi; M T Whitehead
Journal:  AJNR Am J Neuroradiol       Date:  2018-04-05       Impact factor: 3.825

5.  Successful tracheal intubation with the GlideScope® in a patient with CHARGE syndrome.

Authors:  Satoshi Shimizu; Tomohiro Koyama; Toshiyuki Mizota; Kazuhiko Fukuda
Journal:  J Anesth       Date:  2013-05-10       Impact factor: 2.078

6.  Two cases of CHARGE syndrome with multiple congenital anomalies.

Authors:  Joo Hyun Chang; Dong Ho Park; Jae Pil Shin; In Taek Kim
Journal:  Int Ophthalmol       Date:  2013-06-27       Impact factor: 2.031

7.  CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.

Authors:  Shun Yan; Rassarin Thienthanasit; Dongquan Chen; Erik Engelen; Joanna Brühl; David K Crossman; Robert Kesterson; Qin Wang; Karim Bouazoune; Kai Jiao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-30       Impact factor: 11.205

8.  Clinical experience in T cell deficient patients.

Authors:  Theresa S Cole; Andrew J Cant
Journal:  Allergy Asthma Clin Immunol       Date:  2010-05-13       Impact factor: 3.406

Review 9.  Genetics of SCID.

Authors:  Fausto Cossu
Journal:  Ital J Pediatr       Date:  2010-11-15       Impact factor: 2.638

10.  CHD7 interacts with BMP R-SMADs to epigenetically regulate cardiogenesis in mice.

Authors:  Yuelong Liu; Cristina Harmelink; Yin Peng; Yunjia Chen; Qin Wang; Kai Jiao
Journal:  Hum Mol Genet       Date:  2013-11-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.